Dr. Hoffman and MAS scientists

Real Deliverables in Our Lifetime

Foundation News Research News

“Traditionally, drug development has been left to pharmaceutical companies,” Charlie explains, “and if they didn’t see a profit margin in it, they didn’t explore it; even if it was good science. By contrast, it’s much scarier for those of us in academia to pursue drug development.” Charlie, or more formally, Charles Hoffman PhD, the Director […]

Click to Read